Sentence examples for proliferation difference from inspiring English sources

No cell proliferation difference was detected (data not shown).

To determine if this proliferation difference was due to differential cell death in these cultures, nuclear matrix protein 41/7 (NMP 41/7) was measured in supernatant by ELISA (Figure 6C).

This latter observation, indicating a proliferation difference between PINCH1−/− and PINCH1fl/fl MEFs likely to influence clonogenic survival, was further analyzed by counting the cell numbers of grown colonies.

Early inactivation of PKD1 resulted in a severe cystic phenotype in the absence of any proliferation difference between wild-type and mutant animals.

Judging by the effectiveness of parthenolide, an anti-inflammatory agent, in reducing the proliferation difference between P20E and P20C, on the other hand (Table 2), there is likely possibility that inflammation itself is contributing to the expression of this phenotype.

There is corresponding proliferation difference between Libyan and Nigerian patients in stages 2 and 3. Lower number of stage 1 cases in Libya may be related to the diagnosis delay and the absence of screening programs for early detection of breast cancer in Libya [ 30].

Therefore, most of the ovarian cancer cell lines were dividing at an approximately equal rate, and gross difference in doubling time is unlikely to be a factor in the observed proliferation differences between cell lines under different conditions.

Basing our predictor on a dataset that originated in a different species and a different cell type may have rendered it less sensitive to proliferation differences and endowed it with wide applicability.

The regional proliferation differences may be inversely dependent to cell-cell contact.

We choose these times of analysis to avoid that possible proliferation differences between cell lines could affect the results.

Thus, we were able to reconstitute the observed proliferation differences between single culture and co-cultures for the alternative responder T cells by addition of recombinant IL-2 to CD25- assays or by deprivation of IL-2 in CD25low assays.